Literature DB >> 22734903

Amyloid-like IgM deposition neuropathy: a distinct clinico-pathologic and proteomic profiled disorder.

Juan J Figueroa1, E Peter Bosch, P James B Dyck, Wolfgang Singer, Julie A Vrana, Jason D Theis, Ahmet Dogan, Christopher J Klein.   

Abstract

Some patients with immunoglobulin paraproteinemic neuropathy have intra-nerve deposits that morphologically mimick amyloid, but do no stain with Congo red. Patients with amyloid-like deposits were identified. The nerve amyloid-like aggregates were studied by laser microdissection and dual mass spectrometry. Three male patients, all with IgM gammopathy, and neuropathy were identified. Follow-up, disease duration was 5, 19, and 7 years, respectively. All had progressive asymmetric sensory-onset distal axonal polyneuropathy with late motor involvement. Autonomic symptoms occurred in only one after 13 years of symptoms. None had clinical cardio-renal involvement. One had skin papules with dermal amyloid-like deposits. Endoneurial amyloid-like deposits had granulo-fibrillar ultrastructure. Mass spectrometry of laser-dissected deposits identified IgM pentameric macroglobulin (heavy, light, and joining chains) without amyloid-associated proteins including absent apolipoprotein E and serum amyloid P-component. Amyloid-like neuropathy has distinct clinical, pathologic, and proteomic features which expand the spectrum of IgM neuropathies. Patients have favorable survival, relative absence of autonomic features, and distinct proteomic profiles of the infiltrative protein in nerve.
© 2012 Peripheral Nerve Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734903      PMCID: PMC3895329          DOI: 10.1111/j.1529-8027.2012.00406.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  32 in total

1.  Polyneuropathy in Waldenstrom's macroglobulinemia. Case report and discussion.

Authors:  J D DARNLEY
Journal:  Neurology       Date:  1962-09       Impact factor: 9.910

2.  [The neuropathies of monoclonal gammapathies. Immunofluorescence and immunolabelling in the electron microscopy of immunoglobulins with amyloid structure (author's transl)].

Authors:  H Carrier; C Guillaud-Barbaret; G Chazot; B Bady; B Schott
Journal:  Acta Neuropathol       Date:  1978-10-13       Impact factor: 17.088

3.  Waldenström's macroglobulinemia and peripheral neuropathy: deposition of M-component and kappa light chain in the endoneurium.

Authors:  C Vital; C Deminière; B Bourgouin; A Lagueny; B David; P Loiseau
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

Review 4.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

5.  Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis.

Authors:  C Meier; K Roberts; A Steck; C Hess; E Miloni; L Tschopp
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Peripheral nerve damage during multiple myeloma and Waldenstrom's macroglobulinemia: an ultrastructural and immunopathologic study.

Authors:  C Vital; J M Vallat; C Deminiere; A Loubet; M J Leboutet
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

7.  Anti-myelin-associated glycoprotein antibodies and endoneurial cryoglobulin deposits responsible for a severe neuropathy.

Authors:  A Vital; A Favereaux; P Martin-Dupont; J L Taupin; K Petry; A Lagueny; M H Canron; C Vital
Journal:  Acta Neuropathol       Date:  2001-10       Impact factor: 17.088

8.  Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis.

Authors:  W H Sherman; N Latov; A P Hays; M Takatsu; R Nemni; G Galassi; E F Osserman
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

9.  Cryoglobulinemic neuropathy: a pathological study.

Authors:  J M Vallat; R Desproges-Gotteron; M J Leboutet; A Loubet; N Gualde; R Treves
Journal:  Ann Neurol       Date:  1980-08       Impact factor: 10.422

10.  Polyneuropathy with monoclonal gammopathy: studies of 11 patients.

Authors:  M C Dalakas; W K Engel
Journal:  Ann Neurol       Date:  1981-07       Impact factor: 10.422

View more
  4 in total

1.  Clinical Neuropathology practice guide 3-2014: combined nerve and muscle biopsy in the diagnostic workup of neuropathy - the Bordeaux experience.

Authors:  Anne Vital; Claude Vital
Journal:  Clin Neuropathol       Date:  2014 May-Jun       Impact factor: 1.368

2.  Repeated treatments with rituximab in a patient with amyloid-like IgM deposition neuropathy.

Authors:  Masato Kadoya; Akiko Kadoya; Hiroyuki Onoue; Katsunori Ikewaki; Jun Shimizu; Kenichi Kaida
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-03-31

Review 3.  Peripheral Nervous System Involvement in Lymphoproliferative Disorders.

Authors:  Mario Sabatelli; Luca Laurenti; Marco Luigetti
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-09-01       Impact factor: 2.576

Review 4.  Amyloid Proteins and Peripheral Neuropathy.

Authors:  Mohammed M H Asiri; Sjoukje Engelsman; Niels Eijkelkamp; Jo W M Höppener
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.